UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The primary aim is to identify the impacts of a behavioral intervention called \"Mindfulness-Based Blood Pressure Reduction\" (MB-BP) vs. enhanced usual care on the primary self-regulation target, specifically an assay of self-related processes (Multidimensional Assessment of Interoceptive Awareness) (MAIA) at 6 months, via a randomized controlled trial.
Epistemonikos ID: 127dd24ed9955a8e0208a77a62832231c808b0c5
First added on: May 22, 2024